Transforming discovery, diagnosis, and innovation
Episode 1 of The hidden future of AI series
Watch on demand
Explore how AI is revolutionizing life sciences by driving advancements in drug discovery, diagnostics, and compliance. Watch this session to uncover the transformative potential of AI and its impact on innovation in healthcare.
- AI-driven drug discovery: Moving from proof-of-concept to practical applications.
- Enhanced diagnostics: AI improving speed and accuracy in imaging.
- LLMs in documentation: Revolutionizing clinical trial records and filings.
- Streamlined trials: Faster patient recruitment with AI-powered platforms.
- Compliance platforms: Real-time regulatory monitoring for life sciences.
Featured Speakers
Dr. Kjell Carlsson
Head of Data Science Strategy, Domino
Dr. Kjell Carlsson advises organizations on how to drive business outcomes with artificial intelligence (AI) and data science. Previously, he covered AI, ML, and data science as a Principal Analyst at Forrester Research where he wrote reports on topics ranging from computer vision, MLOps, AutoML, and conversation intelligence to augmented intelligence, next-generation AI technologies, and data science best practices.
Chris McSpiritt
VP, Life Sciences Strategy
Christopher McSpiritt is a seasoned business architect, consultant, and product leader who has spent almost two decades specializing in helping life sciences organizations improve drug development processes through process reengineering efforts and the deployment of innovative software/analytics solutions. As VP of Life Sciences Strategy at Domino Data Lab, he leads Domino's go-to-market and product strategy for the pharmaceutical industry.